Format

Send to

Choose Destination
AIDS. 2005 Sep 2;19(13):1367-74.

The International HIV Dementia Scale: a new rapid screening test for HIV dementia.

Author information

1
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA. sacktor@jhmi.edu

Abstract

OBJECTIVE:

HIV dementia is an important neurological complication of advanced HIV infection. The use of a cross-cultural screening test to detect HIV dementia within the international community is critical for diagnosing this condition. The objective of this study was to evaluate the sensitivity and specificity of a new screening test for HIV dementia, the International HIV Dementia Scale (IHDS) in cohorts from the US and Uganda.

DESIGN:

Two cross-sectional cohort studies designed to evaluate for the presence of HIV dementia.

METHODS:

Sixty-six HIV-positive individuals in the US and 81 HIV-positive individuals in Uganda received the IHDS and full standardized neurological and neuropsychological assessments. The sensitivity and specificity of varying cut-off scores of the IHDS were evaluated in the two cohorts.

RESULTS:

In the US cohort, the mean IHDS score for HIV-positive individuals without dementia and with dementia were 10.6 and 9.3 respectively (P < 0.001). Using the cut-off of < or = 10, the sensitivity and specificity for HIV dementia with the IHDS were 80% and 57% respectively in the US cohort, and 80% and 55% respectively in the Uganda cohort.

CONCLUSIONS:

The IHDS may be a useful screening test to identify individuals at risk for HIV dementia in both the industrialized world and the developing world. Full neuropsychological testing should then be performed to confirm a diagnosis of HIV dementia.

PMID:
16103767
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center